Introduction of bovine-based nutrient fortifier and gastrointestinal inflammation in very low birth weight infants as measured by fecal calprotectin

Breastfeeding Medicine

Volumn 11, Issue 1, 2016, Pages 2-5

  Panczuk, Julia K ^a   Unger, Sharon ^a,b   Francis, Jane ^c   Bando, Nicole ^c   Kiss, Alex ^d   O'Connor, Deborah L ^c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Canada   (Canada)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; FECAL CALPROTECTIN; UNCLASSIFIED DRUG;

ARTICLE; BIRTH; BREAST FEEDING; BREAST MILK; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM INFLAMMATION; FECES ANALYSIS; FEMALE; HUMAN; INFANCY; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIMILAC; VERY LOW BIRTH WEIGHT; ANIMAL; ARTIFICIAL MILK; BOVINE; CHEMISTRY; FECES; FORTIFIED FOOD; GASTROENTERITIS; INFANT NUTRITION; METABOLISM; MICROBIOLOGY; NEWBORN; PROSPECTIVE STUDY;

ANIMALS; BIOMARKERS; BREAST FEEDING; CATTLE; FECES; FOOD, FORTIFIED; GASTROENTERITIS; HUMANS; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LEUKOCYTE L1 ANTIGEN COMPLEX; PROSPECTIVE STUDIES;

EID: 84955606599     PISSN: 15568253     EISSN: 15568342     Source Type: Journal    
DOI: 10.1089/bfm.2015.0125     Document Type: Article

References (22)

1. Dale I, Brandtzaeg P, Fagerhol MK, et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes: Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol. 1985; 84: 24-34.
2. Steinbakk M, Naess-Andresen CF, Lingaas E, et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 1990; 336: 763-765.
3. Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin: Validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001; 33: 14-22.
4. Campeotto F, Butel MJ, Kalach N, et al. High faecal calprotectin concentrations in newborns infants. Arch Dis Child Fetal Neonatal Ed. 2004; 89: F353-F355.
5. Nissen AC, Van Gils CE, Menheere PP, et al. Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr. 2004; 38: 107-108.
6. Campeotto F, Kalach N, Lapillonne A, et al. Time course of faecal calprotectin in preterm newborns during the first month of life. Acta Paediatr. 2007; 96: 1531-1533.
7. Yang Q, Smith PB, Goldberg RN, et al. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology. 2008; 94: 267-271.
8. Rouge C, Butel MJ, Piloquet H, et al. Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One. 2010; 5: e11083.
9. Josefsson S, Bunn SK, Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr. 2007; 44: 407-413.
10. Laforgia N, Baldassarre ME, Pontrelli G, et al. Calprotectin levels in meconium. Acta Paediatr. 2003; 92: 463-466.
11. Carroll D, Corfield A, Spicer R, et al. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet. 2003; 361: 310-311.
12. Aydemir O, Aydemir C, Sarikabadayi YU, et al. Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. Matern Fetal Neonatal Med. 2012; 25: 2237-2241.
13. Campeotto F, Baldassarre M, Butel MJ, et al. Fecal calprotectin: Cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr. 2009; 48: 507-510.
14. Zopelli L, Güttel C, Bittrich HJ, et al. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology. 2012; 102: 68-74.
15. Quigley MA, Henderson G, Anthony MY, et al. Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2007; (4): CD002971.
16. Friel JK, Diehl-Jones B, Cockell KA, et al. Evidence of oxidative stress in relation to feeding type during early life in premature infants. Pediatr Res. 2011; 69: 160-164.
17. Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010; 156: 562-567.
18. Lambert DK, Christensen RD, Baer VL, et al. Fulminant necrotizing enterocolitis in a multihospital healthcare sytem. J Perinatol. 2012; 32: 194-198.
19. Neu J, Walker AM. Necrotizing enterocolitis. N Engl J Med. 2011; 364: 255-264.
20. Pearson F, Johnson MJ, Leaf AA. Milk osmolality: Does it matter?. Arch Dis Child Fetal Med Ed. 2013; 98: F166-F169.
21. Penn AH, Altshuler AE, Small JW, et al. Digested formula but not digested fresh human milk causes death of intestinal cells in vitro: Implications for necrotizing enterocolitis. Pediatr Res. 2012; 72: 560.
22. Polycarpou E, Zachaki S, Papaevangelou V, et al. Oral larginine supplementation and faecal calprotectin levels in very low birth weight neonates. Perinatology. 2013; 33: 141-146.